Publications

• Aleukemic Chronic Myeloid Leukemia Without Neutrophilia and Thrombocytosis: A Report From the BCR::ABL1 Pathology Group.
  Mod Pathol Volume: 37 Page(s): 100406
  02/01/2024 Authors: Rivera D; Cui W; Gao J; Peker D; Zhang Q-Y; Dewar R; Qiu L; Konoplev S; Hu Z; Sasaki K
• Genetics and pathologic landscape of lineage switch of acute leukemia during therapy.
  Blood Cancer J Volume: 14 Page(s): 19
  01/25/2024 Authors: Zhou T; Curry CV; Khanlari M; Shi M; Cui W; Peker D; Chen W; Wang E; Gao J; Shen Q
• Important Considerations in the Diagnosis and Management of Post-transplant Lymphoproliferative Disorder.
  Curr Oncol Rep Volume: 25 Page(s): 883 - 895
  08/01/2023 Authors: Lee M; Abousaud A; Harkins RA; Marin E; Balasubramani D; Churnetski MC; Peker D; Singh A; Koff JL
• T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases.
  Am J Clin Pathol Volume: 159 Page(s): 325 - 336
  04/04/2023 Authors: Hu Z; Medeiros LJ; Xu M; Yuan J; Peker D; Shao L; Tang Z; Mai B; Thakral B; Rios A
• Essential Thrombocythemia and Post-Essential Thrombocythemia Myelofibrosis: Updates on Diagnosis, Clinical Aspects, and Management.
  Lab Med Volume: 54 Page(s): 13 - 22
  01/05/2023 Authors: Puglianini OC; Peker D; Zhang L; Papadantonakis N
• Best Practices in CD30 Immunohistochemistry Testing, Interpretation, and Reporting: An Expert Panel Consensus.
  Arch Pathol Lab Med Volume: 147 Page(s): 79 - 86
  01/01/2023 Authors: Gru AA; Lim MS; Dogan A; Horwitz SM; Delabie J; Fu K; Peker D; Reddy VVB; Xu ML; Vij K
• Next-Generation Sequencing Identifies Frequent FLT3 N676K Mutations in Myeloid Neoplasms
  Volume: 24 Page(s): S42 - S42
  10/01/2022 Authors: Magallanes-Hoyos M; Mani C; Xie W; Dunlap J; Wang H; Peker D; Bessonen K; Karner K; Viswanatha D; Kovacsovics T
• The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms.
  Blood Volume: 140 Page(s): 716 - 755
  08/18/2022 Authors: Li P; Brown S; Williams M; White T; Xie W; Cui W; Peker D; Lei L; Kunder CA; Wang H-Y
• AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome.
  Leukemia Volume: 36 Page(s): 664 - 674
  03/01/2022 Authors: Li P; White T; Xie W; Cui W; Peker D; Zeng G; Wang H-Y; Vagher J; Brown S; Williams M
• The need for new test verification and regulatory support for innovative diagnostics.
  Nat Biotechnol Volume: 39 Page(s): 1060 - 1062
  09/01/2021 Authors: Roback JD; Tyburski EA; Alter D; Asakrah S; Chahroudi A; Esper A; Farmer S; Figueroa J; K Frediani J; D Gonzalez M
• Increased Expression of GPR137 is Associated With Adverse Prognosis in AML
  Volume: 101 Page(s): 802 - 804
  03/01/2021 Authors: Alvey E; Kornfield A; Peker D
• T-Cell Prolymphocytic Leukemia (T-PLL) with t(X;14)(q28; q11.2): A Report of 17 Cases
  Volume: 101 Page(s): 844 - 844
  03/01/2021 Authors: Hu Z; Xu M; Yuan J; Peker D; Shao L; Rios A; Medeiros LJ; Hu S
• T-Cell Prolymphocytic Leukemia (T-PLL) with t(X;14)(q28; q11.2): A Report of 17 Cases
  Volume: 34 Page(s): 844 - 844
  03/01/2021 Authors: Hu Z; Xu M; Yuan J; Peker D; Shao L; Rios A; Medeiros LJ; Hu S
• Increased Expression of GPR137 is Associated With Adverse Prognosis in AML
  Volume: 34 Page(s): 802 - 804
  03/01/2021 Authors: Alvey E; Kornfield A; Peker D
• EBV Positive Mucocutaneous Ulcer (EBVMCU): Single Center Series of Three Cases and Review of Literature.
  Ann Clin Lab Sci Volume: 51 Page(s): 124 - 130
  01/01/2021 Authors: Fei F; Reddy V; Peker D; Patel C; Al Diffalha S
• Clinicopathologic and Molecular Analysis of Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma: A Case Report and Review of Literature.
  Turk Patoloji Derg Volume: 37 Page(s): 266 - 272
  01/01/2021 Authors: Morales-Vargas B; Deeb K; Peker D
• A Single Institution Experience in EBV Positive Mucocutaneous Ulcer: A New Entity of 2017 WHO
  Volume: 100 Page(s): 658 - 660
  03/01/2020 Authors: Fei F; Reddy V; Peker D; Patel C; Dhall D; Lee G; Al Diffalha S
• A Single Institution Experience in EBV Positive Mucocutaneous Ulcer: A New Entity of 2017 WHO
  Volume: 33 Page(s): 658 - 660
  03/01/2020 Authors: Fei F; Reddy V; Peker D; Patel C; Dhall D; Lee G; Al Diffalha S
• Ramp-up Treatment Strategy in Philadelphia Positive Acute Lymphoblastic Leukemia Is Associated with Deep Molecular Remissions and Favorable Outcomes
  Volume: 134
  11/13/2019 Authors: Mir NA; Bodine C; Peker D; Bachiashvili K; Vachhani P; Costa LJ; Erba HP; Papadantonakis N
• Bone Pathology for Hematopathologists.
  Surg Pathol Clin Volume: 12 Page(s): 831 - 847
  09/01/2019 Authors: Peker D; Wei S; Siegal GP
• Clinicopathological and molecular characteristics of extramedullary acute myeloid leukaemia.
  Histopathology Volume: 75 Page(s): 185 - 192
  08/01/2019 Authors: Ullman DI; Dorn D; Jones JA; Fasciano D; Ping Z; Kanakis C; Koenig RG; Salzman D; Peker D
• Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
  J Natl Compr Canc Netw Volume: 17 Page(s): 721 - 749
  06/01/2019 Authors: Tallman MS; Wang ES; Altman JK; Appelbaum FR; Bhatt VR; Bixby D; Coutre SE; De Lima M; Fathi AT; Fiorella M
• Abstracts of Presentations at the Association of Clinical Scientists 139th Meeting Hershey, PA, May 15-18, 2019.
  Ann Clin Lab Sci Volume: 49 Page(s): 403 - 416
  05/01/2019 Authors: Donaldson K; Buchanich JM; Grigson PS; Deneke E; Donaldson K; Vrana KE; Sacks DB; Kuehn GJ; Cardamone D; Pesce A
• Loss of 5-Hydroxymethylcytosine is an Epigenetic Hallmark in Nodular Lymphocyte Predominant Hodgkin Lymphoma, a Novel Discovery
  Volume: 32
  03/01/2019 Authors: Xu SA; Peker D; Huang Q; Alkan S
• Phenotypic Shift in Blasts in Post-Treatment Acute Myeloid Leukemia and its Effect on Clinical Course
  Volume: 32
  03/01/2019 Authors: Raniah AA; Fei F; Rosenblum F; Peker D
• Characterization of Cancer Immune Profiles in Patients with Primary Central Nervous System Lymphoma
  Volume: 32
  03/01/2019 Authors: Fei F; Raniah AA; Peker D
• Characterization of Cancer Immune Profiles in Patients with Primary Central Nervous System Lymphoma
  Volume: 99
  03/01/2019 Authors: Fei F; Raniah AA; Peker D
• Loss of 5-Hydroxymethylcytosine is an Epigenetic Hallmark in Nodular Lymphocyte Predominant Hodgkin Lymphoma, a Novel Discovery
  Volume: 99
  03/01/2019 Authors: Xu SA; Peker D; Huang Q; Alkan S
• Phenotypic Shift in Blasts in Post-Treatment Acute Myeloid Leukemia and its Effect on Clinical Course
  Volume: 99
  03/01/2019 Authors: Raniah AA; Fei F; Rosenblum F; Peker D
• Systemic Non-Hodgkin T Cell Lymphomas Presenting in the Head and Neck Region: An Institutional Experience of a Rare Entity.
  Head Neck Pathol Volume: 12 Page(s): 481 - 487
  12/01/2018 Authors: Broadwater DR; Peker D
• The Impact of Cumulative Dose of Cytarabine Consolidation on Outcomes in Older Patients with Acute Myeloid Leukemia
  Volume: 132
  11/29/2018 Authors: Stanko LM; Costa LJ; Peker D; Erba HP; Papadantonakis N
• Clinicopathologic Features and Clinical Outcome Differences in De Novo Versus Secondary Histiocytic Sarcomas: A Multi-institutional Experience and Review of the Literature.
  Clin Lymphoma Myeloma Leuk Volume: 18 Page(s): e427 - e435
  10/01/2018 Authors: Broadwater DR; Conant JL; Czuchlewski DR; Hall JM; Wei S; Siegal GP; Peker D
• Overexpression of Methylenetetrahydrofolate Dehydrogenase 1 (MTHFD1L) in Colorectal Cancer: A Potential Therapeutic Target
  Volume: 150 Page(s): S43 - S44
  10/01/2018 Authors: Wang K; Duncan V; Agarwal S; Varambally S; Peker D
• CNS involvement in Peripheral T-cell lymphoma, a rare presentation.
  Volume: 77 Page(s): 515 - 515
  06/01/2018 Authors: Youssef M; Peker D; Hackney JR
• Therapy-associated myelodysplastic syndrome with monosomy 7 arising in a Muir-Torre Syndrome patient carrying SETBP1 mutation.
  Mol Clin Oncol Volume: 8 Page(s): 306 - 309
  02/01/2018 Authors: Ullman D; Baumgartner E; Wnukowski N; Koenig G; Mikhail FM; Pavlidakey P; Peker D
• Postradiation Histiocytic Sarcoma in the Setting of Muir-Torre Syndrome.
  Case Rep Pathol Volume: 2018 Page(s): 5947870
  01/01/2018 Authors: Baumgartner E; Ullman D; Jones JA; Fasciano D; Atherton DS; Pavlidakey P; Peker D
• Apoptotic Osteocytes Promote Myeloma Dissemination to New Bone Sites Via Suppression of Immune Surveillance in Bone Marrow
  Volume: 130
  12/07/2017 Authors: Hao X; Feng R; Trotter T; Gowda P; Fok M; Xu X; Peker D; Javed A; Yang Y
• MLK4 IS REQUIRED FOR METASTASIS INITIATION IN THE BRAIN
  Volume: 19 Page(s): 250 - 250
  11/01/2017 Authors: Alsheikh HA; Minata M; Yamaguchi S; Harada S; Peker D; Samant R; Tannous B; Bhat K; Cerione R; Zhang S
• HIGH ALDEHYDE DEHYDROGENASE ACTIVITY IDENTIFIES BRAIN METASTASIS-INITIATING CELLS IN BREAST CANCER
  Volume: 19 Page(s): 244 - 244
  11/01/2017 Authors: Minata M; Alsheikh HA; Harada S; Peker D; Gillespie Y; Cerione R; Tannous B; Nakano I; Samant R; Lu S
• Grading and Prognostication of Neuroendocrine Tumors of the Pancreas: A Comparison Study of Ki67 and PHH3.
  J Histochem Cytochem Volume: 65 Page(s): 399 - 405
  07/01/2017 Authors: Tracht J; Zhang K; Peker D
• Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.
  J Natl Compr Canc Netw Volume: 15 Page(s): 926 - 957
  07/01/2017 Authors: O'Donnell MR; Tallman MS; Abboud CN; Altman JK; Appelbaum FR; Arber DA; Bhatt V; Bixby D; Blum W; Coutre SE
• Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies.
  Am J Hematol Volume: 92 Page(s): 161 - 170
  02/01/2017 Authors: Costa LJ; Maddocks K; Epperla N; Reddy NM; Karmali R; Umyarova E; Bachanova V; Costa C; Glenn MJ; Chavez JC
• De Novo Purine Biosynthetic Enzyme PAICS Upregulation in Diffuse Large B-Cell Lymphoma: Is It a Potential Target?
  Volume: 30 Page(s): 350A - 350A
  02/01/2017 Authors: Gibson B; Drwiega J; Gordetsky J; Roman-Holba S; Kwon Y; Yang Y; Varambally S; Chakravarthi BVSK; Peker D
• De Novo Purine Biosynthetic Enzyme PAICS Upregulation in Diffuse Large B-Cell Lymphoma: Is It a Potential Target?
  Volume: 97 Page(s): 350A - 350A
  02/01/2017 Authors: Gibson B; Drwiega J; Gordetsky J; Roman-Holba S; Kwon Y; Yang Y; Varambally S; Chakravarthi BVSK; Peker D
• Loss of RUNX3 expression is an independent adverse prognostic factor in diffuse large B-cell lymphoma.
  Leuk Lymphoma Volume: 58 Page(s): 179 - 184
  01/01/2017 Authors: Duncan VE; Ping Z; Varambally S; Peker D
• Increased Expression of EZH2 Is Associated with Inferior Survival in Primary Central Nervous System Diffuse Large B-Cell Lymphoma
  Volume: 128
  12/02/2016 Authors: Gibson B; Matnani R; Ping Z; Chakravarthi BVSK; Yang Y; Varambally S; Peker D
• Adipocyte-Lineage Cells Support Growth and Dissemination of Multiple Myeloma in Bone.
  Volume: 186 Page(s): 3054 - 3063
  11/01/2016 Authors: Trotter TN; Gibson JT; Sherpa TL; Gowda PS; Peker D; Yang Y
• The Role of RUNX3 in Colorectal Tumor Progression
  Volume: 146 Page(s): S129 - S129
  09/01/2016 Authors: Duncan V; Peker D
• Down-regulation of RUNX3 expression in solid tumours metastatic to the brain
  Volume: 469 Page(s): S205 - S205
  09/01/2016 Authors: Peker D; Chakravarthi B; Siegal G; Varatnbally S; Harada S
• Preface.
  Volume: 109 Page(s): 494
  09/01/2016 Authors: Stewart R; Peker D
• Is Low Positive JAK2 V617F Mutation Test Result Clinically Significant?: Multi-Institutional Study.
  Appl Immunohistochem Mol Morphol Volume: 24 Page(s): 589 - 594
  09/01/2016 Authors: Wu X; Lee JW; Peker D; Spitzer SG; Laser J; Reddy VVB; Harada S
• Extramedullary Involvement by Chronic Myelogeneous Leukemia in Five Patients With Unusual Clinicopathologic Features: A Review of the Effectiveness of Tyrosine Kinase Inhibitors.
  J Clin Med Res Volume: 8 Page(s): 480 - 485
  06/01/2016 Authors: Soni A; Paluri R; Deal T; Peker D
• Heparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cells.
  Oncotarget Volume: 7 Page(s): 11299 - 11309
  03/08/2016 Authors: Li J; Pan Q; Rowan PD; Trotter TN; Peker D; Regal KM; Javed A; Suva LJ; Yang Y
• Outcomes of Allogeneic Stem Cell Transplantation (alloSCT) for Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome
  Volume: 22 Page(s): S346 - S347
  03/01/2016 Authors: Peker D; Jamil MO; Salzman D; Jackson BE; Borate U
• Early Allogeneic Stem Cell Transplantation Appears to Improve Outcomes in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/T-LBL) Patients: A Multi-Institutional Review
  Volume: 22 Page(s): S202 - S202
  03/01/2016 Authors: Hathaway AR; Peker D; Jackson BE; Kota VK; Shah BD; Zhang L; Jillella AP; Arellano M; Heffner LT; Erba HP
• RUNX3: A New Prognostic Marker in Diffuse Large B-Cell Lymphoma?
  Volume: 29 Page(s): 342A - 342A
  02/01/2016 Authors: Duncan VE; Varambally S; Peker D
• RUNX3: A New Prognostic Marker in Diffuse Large B-Cell Lymphoma?
  Volume: 96 Page(s): 342A - 342A
  02/01/2016 Authors: Duncan VE; Varambally S; Peker D
• Perivesical unicentric Castleman disease initially suspected to be metastatic prostate cancer.
  Urol Ann Volume: 8 Page(s): 245 - 248
  01/01/2016 Authors: Guthrie PJ; Thomas JV; Peker D; Turkbey B; Rais-Bahrami S
• Clinicopathologic and cytogenetic characterization of therapy-related acute T lymphoblastic leukemia in adult population.
  Leuk Lymphoma Volume: 57 Page(s): 1460 - 1462
  01/01/2016 Authors: Parekh V; Peker D
• The Role of Adipocyte Lineage Cells in Myeloma Growth and Dissemination in Bone
  Volume: 126
  12/03/2015 Authors: Trotter TN; Lama-Sherpa TD; Peker D; Javed A; Suva LJ; Yang Y
• Differences in Cell of Origin (COO) Affect Outcomes in Caucasian(C) but Not in African American(AA) Patients with Diffuse Large B-Cell Lymphoma(DLBCL)
  Volume: 126
  12/03/2015 Authors: Borate U; Peker D; Foran JM; Costa LJ
• Early Allogeneic Stem Cell Transplantation and Use of Asparaginase during Induction Chemotherapy Appear to Improve Otherwise Poor Outcomes in Adult T Cell Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/T-LBL) Patients: A Multi Institutional Review
  Volume: 126
  12/03/2015 Authors: Borate U; Hathaway AR; Peker D; Jackson BE; Kota VK; Shah BD; Zhang L; Jillella A; Arellano M; Heffner LT
• Multi-Institution Review of Adult Early T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma (ETP-ALL)
  Volume: 126
  12/03/2015 Authors: Shah BD; Borate U; Kota VK; Zhang L; Peker D; Hathaway AR; Chavez JC
• Plasmablastic microlymphoma arising in human herpesvirus-8-associated multicentric Castleman disease in a human immunodeficiency virus-seronegative patient with clinical response to anti-interleukin-6 therapy.
  Histopathology Volume: 67 Page(s): 930 - 932
  12/01/2015 Authors: Koenig G; Stevens TM; Peker D
• Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.
  Hematol Oncol Volume: 33 Page(s): 206 - 211
  12/01/2015 Authors: Paluri R; Nabell L; Borak S; Peker D
• EBV-related primary splenic lymphocyte-depleted classical Hodgkin lymphoma.
  J Clin Pathol Volume: 68 Page(s): 947 - 950
  11/01/2015 Authors: Parekh V; Peker D
• Expression and functional analysis of aurora kinase A/B in double hit and triple hit B-cell lymphomas
  Volume: 13
  10/01/2015 Authors: Cinar M; Peker D; Akyurek N; Huang Q; Lopategui J; Cinar B; Alkan S
• Prognostication of High-Grade Diffuse Large B-Cell Lymphoma and the Role of MYC, BCL2, and Phosphohistone H3
  Volume: 144 Page(s): A145 - A145
  10/01/2015 Authors: Dai Q; Harada S; Peker D
• Therapy-related B-lymphoblastic leukemia associated with Philadelphia chromosome and MLL rearrangement: Single institution experience and the review of the literature.
  Pathol Int Volume: 65 Page(s): 536 - 540
  10/01/2015 Authors: Matnani R; Parekh V; Borate U; Brazelton J; Reddy V; Peker D
• Malignant Transformation in Von-Meyenburg Complexes: Histologic and Immunohistochemical Clues With Illustrative Cases.
  Appl Immunohistochem Mol Morphol Volume: 23 Page(s): 607 - 614
  10/01/2015 Authors: Parekh V; Peker D
• Myeloma cell-derived Runx2 promotes myeloma progression in bone.
  Blood Volume: 125 Page(s): 3598 - 3608
  06/04/2015 Authors: Trotter TN; Li M; Pan Q; Peker D; Rowan PD; Li J; Zhan F; Suva LJ; Javed A; Yang Y
• THERAPY-RELATED ACUTE MYELOID LEUKEMIA IN ADULTS: IS AGE YOUNGER THAN 40 CLINICALLY RELEVANT?
  Volume: 100 Page(s): 376 - 376
  06/01/2015 Authors: Rosenblum F; Parekh V; Reddy V; Peker D
• Molecular Cytogenetic Features of Primary Central Nervous System Lymphoma
  Volume: 28 Page(s): 371A - 371A
  02/01/2015 Authors: Peker D; Matnani R; Houldsworth J; Hackney J
• Analysis of Aurora Kinase A and B in Double Hit and Triple Hit Lymphomas
  Volume: 28 Page(s): 340A - 340A
  02/01/2015 Authors: Cinar M; Peker D; Akyurek N; Huang Q; Lopategui J; Cinar B; Alkan S
• Molecular Cytogenetic Features of Primary Central Nervous System Lymphoma
  Volume: 95 Page(s): 371A - 371A
  02/01/2015 Authors: Peker D; Matnani R; Houldsworth J; Hackney J
• Analysis of Aurora Kinase A and B in Double Hit and Triple Hit Lymphomas
  Volume: 95 Page(s): 340A - 340A
  02/01/2015 Authors: Cinar M; Peker D; Altyurek N; Huang Q; Lopategui J; Cinar B; Alkan S
• A close association of autoimmune-mediated processes and autoimmune disorders with chronic myelomonocytic leukemia: observation from a single institution.
  Acta Haematol Volume: 133 Page(s): 249 - 256
  01/01/2015 Authors: Peker D; Padron E; Bennett JM; Zhang X; Horna P; Epling-Burnette PK; Lancet JE; Pinilla-Ibarz J; Moscinski L; List AF
• Myeloma Cell-Derived Runx2 Promotes Myeloma Progression and Bone-Homing
  Volume: 124
  12/06/2014 Authors: Li M; Trotter TN; Peker D; Rowan PD; Pan Q; Larry SJ; Javed A; Yang Y
• Heparanase Promotes Myeloma Metastasis By Inducing EMT-like Features in Both Myeloma Cells and Endothelial Cells
  Volume: 124
  12/06/2014 Authors: Pan Q; Rowan PD; Innis-Shelton R; Trotter TN; Li M; Peker D; Suva LJ; Yang Y
• An extremely rare primary gallbladder myxoid liposarcoma associated with amplification of DDIT3 gene.
  J Gastrointestin Liver Dis Volume: 23 Page(s): 460 - 461
  12/01/2014 Authors: Ma Y; Wei S; Peker D
• Azathioprine induced Epstein Barr virus-positive mucocutaneous ulcer arising in perianal fistula and abscess associated with Crohn's disease.
  J Crohns Colitis Volume: 8 Page(s): 1747 - 1748
  12/01/2014 Authors: Matnani R; Peker D
• Clinicopathological and molecular features of myeloid sarcoma as initial presentation of therapy-related myeloid neoplasms: a single institution experience.
  Int J Hematol Volume: 100 Page(s): 457 - 463
  11/01/2014 Authors: Peker D; Parekh V; Paluri R; Deal T; Borate U; Di Stasi A; Harada S; Arroyo EA; Reddy V
• Littoral-Cell Angioma Presenting as Spontaneous Splenic Rupture: Report of a Rare Case
  Volume: 142
  10/01/2014 Authors: Parekh V; Peker D
• An Unusual Case of FIP1L1-PDGFRA Fusion Gene-Positive Myeloproliferative Neoplasm Initially Presenting as Intratechal Myeloid Sarcoma
  Volume: 142
  10/01/2014 Authors: Koenig R; Reddy V; Peker D
• Extramedullary Blast Crisis in Chronic Myelogenous Leukemia: A Case Series of Unusual Clinicopathological Features
  Volume: 142
  10/01/2014 Authors: Soni A; Deal T; Peker D
• Temporomandibular joint arthritis as an initial presentation of acute myeloid leukemia with myelodysplasia-related changes: a report of an unusual case.
  J Oral Maxillofac Surg Volume: 72 Page(s): 1677 - 1683
  09/01/2014 Authors: Brazelton J; Louis P; Sullivan J; Peker D
• Clinicopathological and Molecular Features of Treatment-Related Myeloid Sarcoma, a Subtype of Treatment-Related Myeloid Neoplasms
  Volume: 94 Page(s): 344A - 345A
  02/01/2014 Authors: Deal TM; Brazelton JD; Harada S; Borate U; Reddy V; Peker DZ
• Does Frequent Expression of CD200 in Adult B-Lymphoblastic Lymphoma Have a Prognostic Value? An Institutional Survival Analysis
  Volume: 94 Page(s): 338A - 338A
  02/01/2014 Authors: Brazelton JD; Deal TM; Peker DZ
• Clinicopathological and Molecular Features of Treatment-Related Myeloid Sarcoma, a Subtype of Treatment-Related Myeloid Neoplasms
  Volume: 27 Page(s): 344A - 345A
  02/01/2014 Authors: Deal TM; Brazelton JD; Harada S; Borate U; Reddy V; Peker DZ
• Does Frequent Expression of CD200 in Adult B-Lymphoblastic Lymphoma Have a Prognostic Value? An Institutional Survival Analysis
  Volume: 27 Page(s): 338A - 338A
  02/01/2014 Authors: Brazelton JD; Deal TM; Peker DZ
• Extramedullary hematopoiesis in uterine leiomyoma associated with numerous intravascular thrombi.
  Case Rep Pathol Volume: 2014 Page(s): 957395
  01/01/2014 Authors: Cui X; Peker D; Greer HO; Conner MG; Novak L
• Novel G377S (c.1246G > T) mutation associated with Gaucher disease type 1
  AMERICAN JOURNAL OF HEMATOLOGY Volume: 88 Page(s): 922 - 923
  10/01/2013 Authors: Zhou Y; Kraemer RR; Peker D; Wakefield DN; Bakula DADI
• Novel G377S (c.1246G>T) mutation associated with Gaucher disease type 1.
  Am J Hematol Volume: 88 Page(s): 922 - 923
  10/01/2013 Authors: Zhou Y; Kraemer RR; Peker D; Wakefield DN; de Idiaquez Bakula DA
• Histologic Glimpse to Cholangiocarcinoma Arising in Von-Meyenburg Complexes: Report of a Rare Case
  Volume: 140 Page(s): 107 - 107
  09/01/2013 Authors: Parekh V; Reddy S; Peker D
• Leiomyoma With Extramedullary Hematopoiesis and Intravascular Thrombosis
  Volume: 140 Page(s): 12 - 12
  09/01/2013 Authors: Cui X; Peker D; Novak L; Conner M
• Bone marrow involvement as initial presentation of CD8 cytotoxic peripheral T-cell lymphoma with CD20 coexpression and relatively indolent clinical course.
  Leuk Lymphoma Volume: 54 Page(s): 1113 - 1116
  05/01/2013 Authors: Zhang Y; Zhang L; Jin X; Zhao H; Hao X; Peker D; Wei S; Sokol L; Moscinski L
• Reticulin fibrosis in disease progression and overall survival of chronic myelomonocytic leukemia: An independent prognostic factor?
  Volume: 37 Page(s): S82 - S82
  05/01/2013 Authors: Peker D; Liu J; Padron E; Lancet J; List A; Komrokji R; Zhang L
• Burkitt lymphoma arising from lymphoplasmacytic lymphoma following acquisition of MYC translocation and loss of the ETV6 tumor suppressor gene.
  Arch Pathol Lab Med Volume: 137 Page(s): 130 - 133
  01/01/2013 Authors: Peker D; Quigley B; Qin D; Papenhausen P; Zhang L
• A Comparison of Prognostic Models for Chronic Myelomonocytic Leukemia (CMML) in the Era of Hypomethylating Agents
  Volume: 120
  11/16/2012 Authors: Padron E; Al Ali NH; Peker D; Lancet JE; Epling-Burnette PK; Zhang L; List AF; Komrokji RS
• A Close Association of History of Autoimmunity with Chronic Myelomonocytic Leukemia (CMML) in Contrast to Chronic Myelogenous Leukemia (CML)
  Volume: 120
  11/16/2012 Authors: Peker D; Padron E; Horna P; Bennett JM; Zhang X; Epling-Burnette PK; Lancet JE; Pinilla J; Moscinski L; List AF
• Double and Triple Hit Diffuse Large B Cell Lymphomas and First Line Therapy
  Volume: 120
  11/16/2012 Authors: Jaglal MV; Peker D; Tao J; Cultrera JL
• Reticulin Fibrosis in Disease Progression and Overall Survival of Chronic Myelomonocytic Leukemia: An Independent Prognostic Factor?
  Volume: 138 Page(s): A048 - A048
  07/01/2012 Authors: Peker D; Liu J; Zhang L
• A review of clinicopathologic characteristics, therapy, and outcomes of 22 patients with aggressive B-cell lymphoma
  Volume: 30
  05/20/2012 Authors: Jaglal M; Peker D; Bello CM; Shah BD; Sokol L; Zhang L; Sotomayor EM; Tao J; Cultrera JL
• Unusual primary presentations of mantle cell lymphoma in the urinary tract and testes.
  Volume: 30
  05/20/2012 Authors: Peker D; Kubal TE; Sotomayor EM; Sokol L; Cultrera JL; Bello CM; Chervenick PA; Sagatys E; Naghashpour M; Zhang L
• Natural history and clinical prognosis of in situ mantle cell lymphoma.
  Volume: 30
  05/20/2012 Authors: Kubal TE; Peker D; Sagatys E; Zhang L; Naghashpour M; Moscinski L; Sotomayor EM; Sokol L; Bello CM; Cultrera JL
• Natural history and clinical prognosis of in situ mantle cell lymphoma.
  Volume: 30
  05/20/2012 Authors: Kubal TE; Peker D; Sagatys E; Zhang L; Naghashpour M; Moscinski L; Sotomayor EM; Sokol L; Bello CM; Cultrera JL
• A composite small lymphocytic lymphoma and Hodgkin transformation presenting as acute appendicitis.
  Ann Hematol Volume: 91 Page(s): 801 - 802
  05/01/2012 Authors: Quigley B; Peker D; Zhang L
• Complete remission in 4 patients with human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin, a novel chemotherapy combination.
  Clin Adv Hematol Oncol Volume: 10 Page(s): 204 - 206
  03/01/2012 Authors: Peker D; Martinez AE; Schwartz MA; Cusnir M
• Paraneoplastic Skin Findings in Patients with Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
  Volume: 25 Page(s): 360A - 361A
  02/01/2012 Authors: Peker D; Moseinski L; Mathew R; Zhang L
• Detection of Clonal T-Cell Large Granular Lymphocytes in Low-Grade Myelodysplastic Syndrome
  Volume: 25 Page(s): 384A - 384A
  02/01/2012 Authors: Zhang X; Moscinski LC; Setoodeh R; Peker D; Zhang L
• Paraneoplastic Skin Findings in Patients with Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
  Volume: 92 Page(s): 360A - 361A
  02/01/2012 Authors: Peker D; Moseinski L; Mathew P; Zhang L
• Detection of Clonal T-Cell Large Granular Lymphocytes in Low-Grade Myelodysplastic Syndrome
  Volume: 92 Page(s): 384A - 384A
  02/01/2012 Authors: Zhang X; Moscinski LC; Setoodeh R; Peker D; Zhang L
• Morphologic and Phenotypic Features of Concurrent Clonal T-Cell Large Granular Lymphocytic Expansion and Myelodysplastic Syndrome
  Volume: 118 Page(s): 1209 - 1209
  11/18/2011 Authors: Zhang X; Moscinski L; Bennett JM; Setoodeh R; Peker D; Zhang L
• Frequent Coexpression of HHV-8 and EBV in HIV-Associated Multicentric Castleman Disease
  Volume: 90 Page(s): 316A - 316A
  02/01/2010 Authors: Peker D; Poppiti R; Yaziji H; Martinez A
• Frequent Coexpression of HHV-8 and EBV in HIV-Associated Multicentric Castleman Disease
  Volume: 23 Page(s): 316A - 316A
  02/01/2010 Authors: Peker D; Poppiti R; Yaziji H; Martinez A
• Refining the Diagnostic Approach in the Evaluation of HER2 in Breast Cancer: A Survey of 2008 Invasive Breast Cancers Comparing a Rabbit Polyclonal Antibody, Rabbit Monoclonal Antibody with Fluorescence In Situ Hybridization
  Volume: 89 Page(s): 63A - 63A
  01/01/2009 Authors: Peker D; Poppiti RJ; Alexis J; Howard L; Saiz E; Yaziji H
• Strong Expression of D2-40 in Lymphoma-Associated Stroma Is Associated with Superior Outcome in Diffuse Large B-Cell Lymphoma
  Volume: 89 Page(s): 280A - 280A
  01/01/2009 Authors: Peker D; Chang CC; Hagemeister F; Zu Y; Ewton A; Curry C; Jones D
• Refining the Diagnostic Approach in the Evaluation of HER2 in Breast Cancer: A Survey of 2008 Invasive Breast Cancers Comparing a Rabbit Polyclonal Antibody, Rabbit Monoclonal Antibody with Fluorescence In Situ Hybridization
  Volume: 22 Page(s): 63A - 63A
  01/01/2009 Authors: Peker D; Poppiti RJ; Alexis J; Howard L; Saiz E; Yaziji H
• Strong Expression of D2-40 in Lymphoma-Associated Stroma Is Associated with Superior Outcome in Diffuse Large B-Cell Lymphoma
  Volume: 22 Page(s): 280A - 280A
  01/01/2009 Authors: Peker D; Chang CC; Hagemeister F; Zu Y; Ewton A; Curry C; Jones D
• Primary schwannoma of lymph node in the retroperitoneal region
  Volume: 451 Page(s): 580 - 580
  08/01/2007 Authors: Peker D; Willis I; Saiz E
• PRIMARY SCHWANNOMA OF LYMPH NODE IN THE RETROPERITONEAL REGION
  Volume: 451 Page(s): 580 - 580
  08/01/2007 Authors: Peker D; Willis I; Saiz E
• Lymphangioma of the ovary: a case report and review of the literature.
  J BUON Volume: 11 Page(s): 91 - 93
  01/01/2006 Authors: Akyildiz EU; Peker D; Ilvan S; Calay Z; Cetinaslan I; Oruc N